Target intelligence / Profile preview

Radiation sensitivity

Molecular classification
Other
01

Overview

Radiation sensitivity, also known as radiosensitivity, refers to the susceptibility of cells, tissues, or organisms to the damaging effects of ionizing radiation. It is not a specific molecule or receptor but rather a biological property determined by multiple factors including DNA damage repair capacity, apoptosis regulation, cellular senescence mechanisms, and epigenetic modifications. Radiosensitivity varies among different cell types; rapidly dividing cells such as lymphocytes and blood-forming cells are generally more sensitive than slowly dividing cells like muscle and nerve tissue. In oncology, understanding the molecular mechanisms underlying radiation sensitivity has led to targeted therapies—such as PARP inhibitors—that exploit defects in DNA repair pathways in cancer cells. Biomarkers based on genetic profiling are increasingly used for patient selection and monitoring efficacy during radiotherapy[1][2]. Note: "Radiation sensitivity" does not refer to a single protein/gene/receptor/enzyme/transporter; it describes a phenotype influenced by many molecular targets. Therefore it should not be treated as an individual therapeutic target according to standard conventions[1][2].

Other names
radiosensitivity
02

Mechanism of action

Modulation of DNA repair pathways to enhance or reduce cellular sensitivity to radiation; Induction of apoptosis and cell cycle arrest via p53-mediated pathways

03

Biological functions

DNA damage responseApoptosisCellular senescenceCell cycle regulationEpigenetic modification
04

Disease associations

Cancer (especially in the context of radiotherapy response)
05

Safety considerations

Not applicable, as "radiation sensitivity" is not a discrete molecular target but a property or phenotype.
06

Interacting drugs

Poly (ADP-ribose) polymerase inhibitors (PARP inhibitors)
07

Biomarkers

Genetic markers and molecular profiling for predicting radiotherapy response

Beyond the preview

Go deeper on Radiation sensitivity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radiation sensitivity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call